Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Sort by

    1. GeoVax Labs, Inc. , a biotechnology company developing human vaccines, announced today that testing of its Ebola vaccine in non-human primates showed 100% protection against a lethal Ebola virus challenge....

    2. There's fever. And unexplained bleeding. Like Ebola. But tests show that the 51 cases in South Sudan are definitely not Ebola.

    3. Single Dose Provided 100% Protection, Tetravalent Hemorrhagic Fever Virus Vaccine Under Development

    4. The last time, we heard about a "mysterious hemorrhagic fever" in a country, it was February 2014. The outbreak was in Guinea. And by the time doctors had pinpointed the culprit, Ebola was spiraling out of control in West Africa. The situation in South Sudan today is a far cry from that in West Africa a few years ago. But it's still concerning, the World Health Organization said . So far, there...

    5. GOVX: GeoVax: Entering into HBV Market

      Zacks Small Cap Research via Yahoo! FinanceJun 07 08:15 AM

      By Grant Zeng, CFA OTC:GOVX On Jun 6, 2016, GeoVax (OTC:GOVX) announced the launch of a program to develop a therapeutic vaccine for treatment of chronic Hepatitis B infections (HBV). This announcement ...

    6. GeoVax: Entering into HBV Market

      Zacks Small Cap Research via Yahoo! FinanceJun 07 08:15 AM

      GeoVax: Entering into HBV Market On Jun 6, 2016, GeoVax  OTCOB:GOVX announced the launch of a program to develop a therapeutic vaccine for treatment of chronic Hepatitis B infections (HBV). This announcement ...

    7. GeoVax Labs, Inc. , a biotechnology company specializing in the development of human vaccines, announced today that its Chief Scientific Officer, Dr. Harriet Robinson, gave an oral presentation at the ...

    8. GeoVax Developing Vaccine to Treat Chronic Hepatitis B Infection

      Marketwired via Yahoo! FinanceJun 06 06:00 AM

      GeoVax Labs, Inc. , a biotechnology company developing human vaccines, announced today the launch of a program to develop a vaccine for treatment of chronic Hepatitis B infections.

    9. ATLANTA, GA--(Marketwired - Jun 21, 2016) - GeoVax Labs, Inc. ( OTCQB : GOVX ), a biotechnology company specializing in the development of human vaccines, announced today that its Chief Scientific Officer, Dr. Harriet Robinson, gave an oral presentation at the American Society for Virology's 35th Annual Meeting, held at Virginia Polytechnic Institute and State University in Blacksburg, Virginia...

    10. SAN FRANCISCO, June 15, 2016 /PRNewswire/ -- The global smart syringes market is expected to reach USD 10.2 billion in 2024, according to a new report by Grand View Research, Inc. In 2015, some key factors ...

    1. Ads
      related to marburg virus
    1. 12323 results